Alnylam sets ambitious five-year plan as sales of key drugs fall short of expectations – statnews.com
& more related News Here
- Alnylam sets ambitious five-year plan as sales of key drugs fall short of expectationsstatnews.com
- Alnylam launches “Alnylam 2030” strategy to drive next era of growth and patient impactbusiness wire
- B of A Securities lowered the price target for ALNY while maintaining a buy rating. ALNY Stock Newsgurufocus
- ALNY: Ambitious 2030 strategy targets global TTR leadership, $10B+ revenues and pipeline expansionTrading View – Track All Markets
- Alnylam stock sinks nearly 7% after Amvutra revenue miss; What to look forward to for ALNYTechstock²